This study will include patients who have either received a stem cell transplant and/or who have developed cancer of the blood or bone marrow.
To be included in the study, your doctor must have a high suspicion that you have invasive infection with Aspergillus. The diagnosis can be pending at the time that you enter the study. Your doctor will perform testing during the study to confirm whether you have or do not have infection with Aspergillus.
Up to 10 research subjects, male or female, age 18 and older, regardless of race or ethnicity, will take part in this study at the Myeloma Institute for Research & Therapy (MIRT).